(Report ID: 108086) Many drug interactions and side effects can not be detected until the drugs have been used by millions of people, and for a long time. Large, long-term drug safety studies are ideal to discover these real-world drug outcomes. For the first time, eHealthMe enables health professionals and patients to conduct these studies for their drugs. Click here to check your drugs now, in a whole new way. As of Nov, 21, 2008, eHealthMe analyzes 10,180,646 drug interactions and side effects of 21,667 FDA-approved drugs from 1977 to the present. Results on Nov, 21, 2008: 2,204 relevant incidents
Note:
- The incidents can not include all actual occurrences
- Data of 2008 is not complete
DISCLAIMER: All adverse drug reaction material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk. Basic information:
| Report ID | Date of submission | Patient age | Patient gender |
| 108086 | Apr, 15, 2006 | 70 | Female |
List of drugs the patient takes:
| Name |
Cancer Pain |
Carbohydrate Antigen 19-9 Increased |
Condition Aggravated |
Disseminated Intravascular Coagulation |
Metastases To Bone Marrow |
Metastatic Gastric Cancer |
Nausea |
Results from eHealthMe: 2,204 relevent incidents1) Comparison with the patient's adverse outcomes:
| Name | Count (% of total reports) |
Cancer Pain | 3 (0.14%) |
Carbohydrate Antigen 19-9 Increased | 4 (0.18%) |
Condition Aggravated | 75 (3.40%) |
Disseminated Intravascular Coagulation | 23 (1.04%) |
Metastases To Bone Marrow | 1 (0.05%) |
Metastatic Gastric Cancer | 1 (0.05%) |
Nausea | 122 (5.54%) |
Death: 6 (4.32% of total reports)
Cancer: 2 (1.44% of total reports)
| Name | Count (% of total reports) |
1 | Pulmonary Embolism | 16 (11.51%) |
2 | Vomiting | 13 (9.35%) |
3 | Nausea | 11 (7.91%) |
4 | Malignant Neoplasm Progression | 9 (6.47%) |
5 | Haemoglobin Decreased | 8 (5.76%) |
6 | Neutrophil Count Decreased | 7 (5.04%) |
7 | General Physical Health Deterioration | 7 (5.04%) |
8 | Fatigue | 7 (5.04%) |
9 | Dehydration | 7 (5.04%) |
10 | Anaemia | 7 (5.04%) |
3) Top co-used drugs drugs reported for the past 12 months:
| Name | Count |
1 | Bevacizumab | 25 |
2 | Emend | 19 |
3 | Iressa | 19 |
4 | Sorafenib | 17 |
5 | Carboplatin | 16 |
6 | Gemcitabine Hcl | 15 |
7 | Kytril | 12 |
8 | Omeprazole | 11 |
9 | Avastin | 11 |
10 | Sodium Chloride 0.9% | 10 |
Death: 58 (2.63% of total reports)
Cancer: 161 (7.30% of total reports)
| Name | Count (% of total reports) |
1 | Pyrexia | 212 (9.62%) |
2 | Thrombocytopenia | 200 (9.07%) |
3 | Neutropenia | 176 (7.99%) |
4 | Dehydration | 134 (6.08%) |
5 | Medication Error | 125 (5.67%) |
6 | Nausea | 122 (5.54%) |
7 | Pulmonary Embolism | 95 (4.31%) |
8 | Platelet Count Decreased | 88 (3.99%) |
9 | Vomiting Nos | 88 (3.99%) |
10 | Haemoglobin Decreased | 85 (3.86%) |
| Name | Count |
1 | Taxol | 302 |
2 | Gemcitabine Hcl | 187 |
3 | Carboplatin | 173 |
4 | Iressa | 153 |
5 | Platinol | 152 |
6 | Dexamethasone | 134 |
7 | Paraplatin | 125 |
8 | Paclitaxel | 122 |
9 | Navelbine | 116 |
10 | Zofran | 107 |
Want to have a risk analysis report like this for your drugs? Click here. ADVERTISEMENT
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Recent drug risk analysis reports:
|
|
|
 |
|
How to use the report?
Bring a copy of this report to a doctor's appointment to ensure drug risks are fully discussed and understood, in the process of risk and benefit assessment.
|
 |
|
ADVERTISEMENT
|
|
